CI

Clinical Infectious Diseases

Clinical Infectious Diseases is an Infectious Diseases Society of America journal published by Oxford University Press.

Looking to publish in Clinical Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology, Infectious Diseases
Impact Factor 7.3
Quartile Q1
Open Access Type Closed
ISSN 1058-4838
eISSN 1537-6591
Invitation Only No

Submission Instructions

Clinical Infectious Diseases accepts the following article types. Click on an article type to view submission instructions.

Original Article

Cover Letter Cover letter requirement is not specified.
Abstract An abstract is required and must not exceed 255 words.
Manuscript No manuscript word limit or required section structure is specified.
References No maximum reference count or citation style is specified.
Figures & Tables No maximum figure/table counts or placement rules are specified.
Reformat to Clinical Infectious Diseases using Livewrite Premium

Review Article

Cover Letter Cover letter requirement is not specified.
Abstract An abstract is required and must not exceed 255 words.
Manuscript A short title must not exceed 40 characters.
References No maximum reference count is indicated.
Figures & Tables Alt text is strongly encouraged for all images, figures, illustrations, and photographs.
Reformat to Clinical Infectious Diseases using Livewrite Premium

Clinical Practice Guideline / Consensus Statement

Cover Letter Cover letter requirement is not specified.
Abstract An abstract is required and must not exceed 255 words.
Manuscript Short title must not exceed 40 characters.
References No maximum reference count is indicated.
Figures & Tables Alt text is strongly encouraged for all images, figures, illustrations, and photographs.
Reformat to Clinical Infectious Diseases using Livewrite Premium

Perspective

Cover Letter Cover letter requirement status and content are not specified.
Abstract An abstract is required and must not exceed 255 words.
Manuscript No specific manuscript word/page limits or section structure are specified.
References No maximum reference count or citation style is specified.
Figures & Tables No maximum figure or table count, placement rules, or formatting constraints are specified.
Reformat to Clinical Infectious Diseases using Livewrite Premium

Case Report

Cover Letter Cover letter requirement is not specified.
Abstract An abstract is required and must not exceed 255 words.
Manuscript A short title must not exceed 40 characters.
References No maximum reference count is indicated.
Figures & Tables Alt text is strongly encouraged for all images, figures, illustrations, and photographs.
Reformat to Clinical Infectious Diseases using Livewrite Premium

Recent Publications

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study

Raphael J Landovitz, Yvett Pinedo, Federico Hinestrosa, Gordon E Crofoot, Cynthia Brinson, Susan Buchbinder, Jean-Michel Molina, Ronnie M Gravett, James B Brock, Moti N Ramgopal, A Lina Rosengren, Igho Ofotokun, Jose Valdez Madruga, Geoffroy Liegeon, Ravindre Panchia, Khuanchai Supparatpinyo, Anchalee Avihingsanon, Catherine Creticos, Shobha Swaminathan, Susanne Doblecki-Lewis, Jorge Rodriguez, Marc Siegel, Shinichi Oka, Thanyawee Puthanakit, Beatriz Grinsztejn, Eduard J Sanders, Javier R Lama, Johannes Lombaard, Nkosiphile Ndlovu, Peggy Hwang, Jiejun Du, Beth Jackson, Brenda Homony, Barbara Evans, Peter Sklar, Michael N Robertson, Rebeca M Plank

10.1093/cid/ciag171
View Publication

Cephalosporins Versus Non-Cephalosporin Antibiotics for Perioperative Prophylaxis in Primary Arthroplasty: A Systematic Review and Meta-Analysis

Rita Igwilo-Alaneme, Elie Berbari, Jack McHugh, Francesco Petri, Vasupriya Ravi, Takahiro Matsuo, Fabio Borgonovo, Said El Zein, M Hassan Murad, Aaron Tande

10.1093/cid/ciag172
View Publication

Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study

Michael A Martin, Alexandra Blenkinsop, Michelle Moffa, Steven James Reynolds, Fred Nalugoda, Thomas C Quinn, Godfrey Kigozi, Robert Ssekubugu, Ravindra K Gupta, Nicholas E Grayson, George MacIntyre-Cockett, Joseph Kagaayi, Gertrude Nakigozi, Lucie Abeler-Dörner, Christophe Fraser, Oliver Ratmann, Aaron A R Tobian, Oliver Laeyendecker, Sikhulile Moyo, Caitlin E Kennedy, David Bonsall, Ronald Moses Galiwango, M Kate Grabowski

10.1093/cid/ciag161
View Publication

When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials

Lindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, Geraint Davies, Jennifer J Furin, Lorenzo Guglielmetti, Norbert Heinrich, Marcus Low, Mariama Mahmoud, Vidya Mave, Norbert Ndjeka, Patrick P J Phillips, Samuel Schumacher, Mark Harrington, Carole D Mitnick

10.1093/cid/ciag175
View Publication

Estimating changes in facility MRSA infection rates due to changes in MRSA precaution policy

Karim Khader, Candace Haroldsen, Vanessa Stevens, Lindsay Visnovsky, Martin Evans, Loretta Simbartl, Brian McCauley, Matthew Samore, Michael Rubin

10.1093/cid/ciag176
View Publication

Frequently asked questions

How long does it take to publish?

Median days to first decision: 6 (with desk rejects) and 39 (without desk rejects). Median days to final decision: 8 (with desk rejects) and 72 (without desk rejects). Online publication occurs within 24–72 hours of acceptance; corrected proofs are published within 3–5 weeks.

Reformat to Clinical Infectious Diseases using Livewrite Premium

Research Topics

Pneumonia and Respiratory Infections HIV/AIDS Research and Interventions Antimicrobial Resistance in Staphylococcus Pneumocystis jirovecii pneumonia detection and treatment Bacterial Identification and Susceptibility Testing Antifungal resistance and susceptibility HIV Research and Treatment Tuberculosis Research and Epidemiology HIV/AIDS drug development and treatment Respiratory viral infections research Antibiotic Resistance in Bacteria Fungal Infections and Studies Streptococcal Infections and Treatments Mycobacterium research and diagnosis Viral gastroenteritis research and epidemiology Antibiotics Pharmacokinetics and Efficacy Bacterial Infections and Vaccines Clostridium difficile and Clostridium perfringens research Infective Endocarditis Diagnosis and Management Antibiotic Use and Resistance Influenza Virus Research Studies Hepatitis C virus research Cytomegalovirus and herpesvirus research SARS-CoV-2 and COVID-19 Research Infectious Diseases and Tuberculosis